Axsome Therapeutics Q3 EPS $(0.56) Misses $(0.4) Estimate

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.4) by 40 percent. This is a 80.65 percent decrease over losses of $(0.31) per share from

Benzinga · 11/07/2019 13:01

Axsome Therapeutics (NASDAQ:AXSM) reported quarterly losses of $(0.56) per share which missed the analyst consensus estimate of $(0.4) by 40 percent. This is a 80.65 percent decrease over losses of $(0.31) per share from the same period last year.